On April 29, 2025, the U.S. Attorney’s Office for the Southern District of New York (SDNY) announced a $202 million civil False Claims Act ...

Trump orders are undermining HIV efforts by barring funds from programs built around diversity, equity, and inclusion. A Day ...

President Donald Trump, in his first term, promised to end America’s HIV epidemic — and he put the resources of the federal ...

Gilead is a vast pharmaceutical multinational. With a $175 billion market capitalisation nothing about the company is going to be small. There's a large HIV treatment arm which gives it a base in ...

Between greetings, Devine, executive director of the nonprofit group Hearts for the Homeless, commiserated with his ...

A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence ...

The global HIV antivirals market is experiencing a period of robust growth, driven by a combination of rising global awareness, remarkable advancements in pharmaceutical research, and the increasing ...